ARTHUR-D.-LITTLE
Disruption, a new book from leading business publisher LID, explores the future of banking in a market where the rules have fundamentally changed. The authors - Ignacio Garcia Alves, Philippe de Backer and Juan Gonzalez - are leading thinkers from one of the world’s top management consulting firms, Arthur D. Little, and draw on many years of experience and insight to outline the challenges that traditional banks face from new competitors and propose a model for change and survival.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220217005013/en/
Disruption includes original interviews and stimulating insights from executives and major players from the world of banking, who openly share their views on the future of financial services and the banking sector. The book provides a critical understanding of the trends within the industry, including the impact of the Covid-19 pandemic, and crucially identifies opportunities for universal banks to leverage their unique assets and pre-empt new entrants from dominating the market.
Ignacio Garcia Alves, Global CEO of Arthur D. Little, says, “Disruption details how a new breed of more agile and aggressive players is disrupting the financial services sector, and advises how traditional banks can deal with the serious challenges they face from these disruptors. It’s a ‘thinking tool’ designed to stimulate action that we hope will particularly resonate with those in the sector who already have a strong sense that banking has fundamentally changed, with its legacy model facing an existential threat.”
“On saying that, it’s not our intention to be alarmist. Instead, we want readers to reflect on what these changes mean for the industry in terms of both risks and opportunities.”
Philippe de Backer, Managing Partner and Global Practice Leader of Financial Services at Arthur D. Little , comments: “We can only conclude from our research and analysis that the traditional banking model we’ve all grown up with is no longer fit for purpose. The rules of the game have changed so fundamentally that banks have no option but to adopt a different model, one that’s much better suited to the world as we now know it. However, this requires both significant investment and a major shift in banking culture.”
Juan Gonzalez, Partner at Arthur D. Little , adds: “The arrival of disruptive, technology-empowered players in the financial market should be a wake-up call to banks, because if they’re to survive the threat they need to move quickly. Banks are conservative organizations that tend to move slowly, but we hope that Disruption will help them to understand the changes that are coming and to ultimately adapt more quickly.”
Paul de Leusse, Chief Executive Officer of Orange Bank , says: “The banking industry has always seen itself protected from the disruption touching all economic sectors. It’s no longer the case. Arthur D. Little tells us why, and more importantly how leaders should prepare for this new world of banking.”
Ricky Knox, founder of Tandem Bank, says: “Disruption provides a provocative view on the technology-driven reshaping of the financial sector. It helps the reader understand how disruptive models are reshaping global economies and consider strategies for effective response.”
Disruption is a must-read for anyone who wants an in-depth analysis of the current state of the banking market and where it’s heading in the future. It is a book for financial services executives who want to be ahead of the curve and make the right decisions to enable their business to thrive rather than stagnate.
The book will be published on 17 February 2022 by LID, the leading business book publishing house in Europe.
To purchase a copy of Disruption , please visit: https://tinyurl.com/5n92uvxh
ENDS
Notes to editors:
- Disruption will be published on 17 February 2022 by LID Publishing
- For more information about Arthur D. Little, please visit www.adlittle.com
- For more information about LID Publishing, please visit www.lidpublishing.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20220217005013/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Data From Landmark HELIOS-B Phase 3 Study Presented at ESC Congress 2025 Demonstrate Vutrisiran’s Long-Term Cardiovascular Benefit in ATTR-CM31.8.2025 11:15:00 CEST | Press release
− Sustained Benefit of Vutrisiran Across Mortality, Cardiovascular Events, Quality of Life and Cardiac Biomarkers Observed Through Up to 48 Months, Including 12 Months from the Ongoing Open-Label Extension, Reinforce Potential as First-Line Treatment for ATTR-CM –− Vutrisiran, which Delivers Rapid Knockdown of Transthyretin, Reduced the Risk of Composite of All-Cause Mortality or First Cardiovascular Event by 37% in the Overall Population and 42% in the Monotherapy Group During the Same Period – Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results of new analyses from the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi therapeutic approved for the treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults. Data from the 12-month follow-up of the ongoing open-label extension (OLE) period of HELIOS-B were presented during an oral session at the European Society of Card
WETEX Opens Broad Investment Horizons for International Companies31.8.2025 08:30:00 CEST | Press release
DEWA will organise the exhibition from 30 September to 2 October 2025 Under the directives of HH Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, and the patronage of HH Sheikh Ahmed bin Saeed Al Maktoum, Chairman of the Dubai Supreme Council of Energy, Dubai Electricity and Water Authority (DEWA) will organise the 27th edition of the Water, Energy, Technology and Environment Exhibition (WETEX) from 30 September to 2 October 2025 at the Dubai World Trade Centre. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250830023664/en/ WETEX opens broad investment horizons for international companies (Photo: AETOSWire) WETEX embodies the UAE's pioneering position in clean and renewable energy and sustainability. It also supports Dubai's ambitious vision of a sustainable economy. The exhibition covers multiple areas including water, energy, smart cities, green mobility, artificial i
Daiichi Sankyo Announces the Initiation of the Development of Oral Triple Combination Lipid-Lowering Tablets to Support the Management of LDL-C30.8.2025 18:00:00 CEST | Press release
Initiation of the development of new oral triple combination tablets, aimed at improving adherence and outcomes in low-density lipoprotein cholesterol (LDL-C) management. Recent findings from MILOS and SANTORINI registries presented at ESC Congress 2025, highlight ongoing challenges in accurately assessing cardiovascular (CV) risk and helping patients reach LDL-C targets.1-5 Furthermore, data from a four-country cohort of the MILOS study support the real-world effectiveness and safety of bempedoic acid in both sexes.6 Simulation using SANTORINI data reveals the potential of improved LDL-C goal attainment with tailored oral combination therapy of statins, ezetimibe and bempedoic acid, in line with the latest 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias.7,8 Daiichi Sankyo has a long-standing commitment to easing treatment of cardiovascular disease (CVD) and exploring new treatment options that improve CVD outcomes and treatment adherence. Daiich
Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial30.8.2025 16:30:00 CEST | Press release
- Phase 3 Trial Informed by KARDIA-3 Phase 2 Study Results Presented as a Late-Breaking Abstract at the European Society of Cardiology Congress 2025 -- Zilebesiran Demonstrated Clinically Meaningful Reductions in Office Systolic Blood Pressure in Patients with Uncontrolled Hypertension and High Cardiovascular Risk at Month 3 Primary Endpoint, with Continuous Control Through Month 6 -- Zilebesiran Displayed Encouraging Safety When Combined with Two or More Antihypertensives -- Results Support Biannual Dosing Regimen and Inform Phase 3 Trial Design: Trial Expected to Initiate by Year-End 2025 -- Alnylam to Host Webcast Investor Event on August 30, 2025, at 1:00 pm ET (7:00 pm CEST) - Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced plans to initiate a Phase 3 cardiovascular outcomes trial (CVOT) to evaluate the potential of zilebesiran to reduce the risk of major adverse cardiovascular events. This decision is informed by results from t
Andersen Consulting styrker sine kompetencer inden for virksomhedstransformation med Fabric29.8.2025 17:01:00 CEST | Pressemeddelelse
Andersen Consulting udvider sin platform gennem en samarbejdsaftale med Fabric, der er et strategisk designfirma, der arbejder med organisationer for at integrere bæredygtighed, forsyningskæder og menneske-centreret innovation på tværs af kultur og drift. Fabric blev grundlagt i Japan i 2021 og arbejder sammen med virksomheder og globale brands om at skabe regenerative forretningsmodeller sammen samt bæredygtige brandstrategier og fremtidssikrede produkter. Ved hjælp af strategiske designmetoder og designfilosofi skaber virksomheden indsigtsbaseret transformation på tværs af forsyningskæder, brand og HR. Fabric er kendt for sin systemtænkning og sit engagement i social og miljømæssig bæredygtighed og fremmer desuden digitale transformationsinitiativer, der integrerer bæredygtighed, humankapital og AI. "Fabric er skabt for at hjælpe virksomheder med at blomstre gennem regenerative relationer til mennesker, samfund og forbundne, levende systemer," sagde James Hollow, der er grundlægger a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom